Kazakhstan Government Proposes Ban on E-Cigarette Sales

Regulations by 2FIRSTS.ai
Nov.28.2023
Kazakhstan Government Proposes Ban on E-Cigarette Sales
Kazakhstan's Health Ministry proposes banning the sale and usage of e-cigarettes to protect public health and pedestrians.

According to a report by Kazinform on November 27th, Rosalina Ermekpaeva, the head of Kazakhstan's Ministry of Health's Committee on Health and Epidemiology, has stated that the country's Ministry of Health recommends banning the sale and use of e-cigarettes.

 

This decision aims to protect the health of citizens and prevent potential threats posed by nicotine products to pedestrians and non-smokers.

 

Currently, the department has formulated a bill to revise the "Regulations," which includes regulations prohibiting the sale, display, and public exhibition of tobacco products (including e-cigarettes with or without nicotine) to individuals under the age of 21, with the aim of prohibiting the circulation of e-cigarettes. The bill is currently under consideration in the lower house of parliament.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions
The U.S. FDA has issued two notices: seeking public comments on regulations regarding tobacco retailer training programs and sales restrictions
On August 22, the U.S. FDA issued two notices soliciting public comments on regulations regarding tobacco retailer training programs and restrictions on tobacco sales. Both notices provide a 60-day public comment period under the Paperwork Reduction Act, aiming to protect public health, especially that of children and adolescents, by regulating retailer behavior and restricting tobacco sales.
Aug.22 by 2FIRSTS.ai
Jakarta’s Smoke-Free Zone Legislation Faces Criticism – Public Health Advocate: “It Will Not Harm Small Businesses”
Jakarta’s Smoke-Free Zone Legislation Faces Criticism – Public Health Advocate: “It Will Not Harm Small Businesses”
Jakarta’s new regulation is expected to improve public health, while experts call for collective efforts to counter misinformation, stressing that smoke-free zone policies can balance both health and economic development.
Aug.20 by 2FIRSTS.ai
Michigan Cannabis Company Recalls 26,000 Vape Cartridges Over Banned Additive in Oil
Michigan Cannabis Company Recalls 26,000 Vape Cartridges Over Banned Additive in Oil
The Michigan Cannabis Regulatory Agency (CRA) announced on August 12 that Sky Cannabis must recall 26,000 cannabis vape cartridges found to contain the prohibited additive MCT oil. The affected products were sold after November 1, 2024, and the recall involves six product types. This marks Michigan’s second product recall in 2025, while nationwide such recalls often fail to recover already sold products due to slow response times.
Aug.14 by 2FIRSTS.ai
Malaysia's Negeri Sembilan Launches 'Save the Lungs' Campaign, Imposes Heavy Fines on Illegal E-Cigarette Sellers
Malaysia's Negeri Sembilan Launches 'Save the Lungs' Campaign, Imposes Heavy Fines on Illegal E-Cigarette Sellers
Malaysia's Negeri Sembilan Health Department launched the 'Save the Lungs Campaign' (Ops Selamat PaPa) to target illegal e-cigarette and cigarette sales. The operation issued 61 fines totaling 12,600 ringgit and initiated investigations into 9 cases. Since the 2024 Public Health Tobacco Control Products Act, 885 enforcement actions have been conducted, inspecting 24,000 stores and issuing 5,606 fines.
Aug.04 by 2FIRSTS.ai
Australian Police Probe Illegal Vaping Network, Freeze $680,000 in Assets
Australian Police Probe Illegal Vaping Network, Freeze $680,000 in Assets
Australia’s AFP, in “Operation Smoke Storm,” froze over AUD 1 million ($680,000) tied to illegal vape sales. Online-branded e-cigarettes and transaction records were seized; funds may support community crime prevention.
Jul.14 by 2FIRSTS.ai
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai